Certified Pediatric Hematology Oncology Nurse (CPHON) Practice Exam 2025 - Free CPHON Practice Questions and Study Guide

The correct answer is related to Non-steroidal anti-inflammatory drugs (NSAIDs) because their use in pediatric patients, especially those with underlying hematological conditions, warrants careful monitoring for side effects that could exacerbate bone marrow failure. Bone marrow failure can lead to decreased production of blood cells, which includes red blood cells, white blood cells, and platelets. NSAIDs can cause gastrointestinal bleeding, which can lead to significant complications, particularly in patients who may already have lower platelet counts due to bone marrow suppression. For these reasons, monitoring NSAID use is crucial in preventing further compromise to the patient's already vulnerable hematologic status.

The other drug classes listed—anxiolytics, antipsychotics, and anticoagulants—do not have a direct relationship with bone marrow failure concerning their primary side effects. While they may have other side effects that could affect general patient health, they are not specifically monitored for issues related to bone marrow function or hematologic abnormalities as NSAIDs are.